Blog
Fed's Hawkish Pause Puts JPMorgan in Focus: Buy, Sell or Hold?
The Federal Reserve’s inflation focus has strengthened expectations that rates will remain elevated. At its July 29 meeting, the central bank held the federal funds rate at 3.50-3.75%, extending its
STX vs. P: Which Storage Stock Deserves a Spot in Your Portfolio?
The AI revolution has dramatically reshaped the data storage industry. As enterprises deploy increasingly sophisticated AI models, demand for both high-capacity storage and high-performance flash
Wall Street Analysts Believe EuroDry (EDRY) Could Rally 30.65%: Here's is How to Trade
Shares of EuroDry (EDRY) have gained 15.5% over the past four weeks to close the last trading session at $25.51, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Believe Nvidia (NVDA) Could Rally 56.03%: Here's is How to Trade
Nvidia (NVDA) closed the last trading session at $195.04, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Nvidia (NVDA) Could Rally 56.03%: Here's is How to Trade
Nvidia (NVDA) closed the last trading session at $195.04, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe EuroDry (EDRY) Could Rally 30.65%: Here's is How to Trade
Shares of EuroDry (EDRY) have gained 15.5% over the past four weeks to close the last trading session at $25.51, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Think Dell Technologies (DELL) Could Surge 25.21%: Read This Before Placing a Bet
Shares of Dell Technologies (DELL) have gained 2.7% over the past four weeks to close the last trading session at $404.81, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?
Shares of MoonLake Immunotherapeutics (MLTX) have gained 0.2% over the past four weeks to close the last trading session at $18.99, but there could still be a solid upside left in the stock if
How Much Upside is Left in Yum China (YUMC)? Wall Street Analysts Think 26.21%
Shares of Yum China Holdings (YUMC) have gained 11.4% over the past four weeks to close the last trading session at $46.47, but there could still be a solid upside left in the stock if short-term
Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?
Shares of Aehr Test Systems (AEHR) have gained 9.9% over the past four weeks to close the last trading session at $76.87, but there could still be a solid upside left in the stock if short-term
Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?
Shares of Aehr Test Systems (AEHR) have gained 9.9% over the past four weeks to close the last trading session at $76.87, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High?
Shares of MoonLake Immunotherapeutics (MLTX) have gained 0.2% over the past four weeks to close the last trading session at $18.99, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?
Prelude Therapeutics Incorporated (PRLD) closed the last trading session at $5.05, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Think Pharvaris (PHVS) Could Surge 43.03%: Read This Before Placing a Bet
Shares of Pharvaris N.V. (PHVS) have gained 0.1% over the past four weeks to close the last trading session at $33.88, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
How Much Upside is Left in Yum China (YUMC)? Wall Street Analysts Think 26.21%
Shares of Yum China Holdings (YUMC) have gained 11.4% over the past four weeks to close the last trading session at $46.47, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?
Prelude Therapeutics Incorporated (PRLD) closed the last trading session at $5.05, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Think Pharvaris (PHVS) Could Surge 43.03%: Read This Before Placing a Bet
Shares of Pharvaris N.V. (PHVS) have gained 0.1% over the past four weeks to close the last trading session at $33.88, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Think Dell Technologies (DELL) Could Surge 25.21%: Read This Before Placing a Bet
Shares of Dell Technologies (DELL) have gained 2.7% over the past four weeks to close the last trading session at $404.81, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Woodward (WWD) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Shares of Woodward (WWD) have been struggling lately and have lost 13.5% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 185.99%: Read This Before Placing a Bet
Shares of Q32 Bio (QTTB) have gained 18.9% over the past four weeks to close the last trading session at $15.56, but there could still be a solid upside left in the stock if short-term price targets
How Much Upside is Left in Broadcom Inc. (AVGO)? Wall Street Analysts Think 33.73%
Broadcom Inc. (AVGO) closed the last trading session at $387.84, gaining 7.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 39.34% Upside in China Yuchai (CYD): Can the Stock Really Move This High?
China Yuchai (CYD) closed the last trading session at $48.32, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
How Much Upside is Left in Broadcom Inc. (AVGO)? Wall Street Analysts Think 33.73%
Broadcom Inc. (AVGO) closed the last trading session at $387.84, gaining 7.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall